These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 16973152)
1. E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor. Yasuda N; Nagakura T; Inoue T; Yamazaki K; Katsutani N; Takenaka O; Clark R; Matsuura F; Emori E; Yoshikawa S; Kira K; Ikuta H; Okada T; Saeki T; Asano O; Tanaka I Eur J Pharmacol; 2006 Oct; 548(1-3):181-7. PubMed ID: 16973152 [TBL] [Abstract][Full Text] [Related]
2. 7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activity. Yamazaki K; Yasuda N; Inoue T; Nagakura T; Kira K; Shinoda M; Saeki T; Tanaka I J Pharmacol Exp Ther; 2006 Dec; 319(3):1253-7. PubMed ID: 16980568 [TBL] [Abstract][Full Text] [Related]
3. Effects of the combination of a dipeptidyl peptidase IV inhibitor and an insulin secretagogue on glucose and insulin levels in mice and rats. Yamazaki K; Yasuda N; Inoue T; Yamamoto E; Sugaya Y; Nagakura T; Shinoda M; Clark R; Saeki T; Tanaka I J Pharmacol Exp Ther; 2007 Feb; 320(2):738-46. PubMed ID: 17093132 [TBL] [Abstract][Full Text] [Related]
4. ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activity. Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Nagase I; Hayakawa M; Shibasaki M Biochem Pharmacol; 2008 Jul; 76(1):98-107. PubMed ID: 18468582 [TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice. Yamazaki K; Inoue T; Yasuda N; Sato Y; Nagakura T; Takenaka O; Clark R; Saeki T; Tanaka I J Pharmacol Sci; 2007 May; 104(1):29-38. PubMed ID: 17485917 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys. Lee B; Shi L; Kassel DB; Asakawa T; Takeuchi K; Christopher RJ Eur J Pharmacol; 2008 Jul; 589(1-3):306-14. PubMed ID: 18538760 [TBL] [Abstract][Full Text] [Related]
7. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors. Thomas L; Eckhardt M; Langkopf E; Tadayyon M; Himmelsbach F; Mark M J Pharmacol Exp Ther; 2008 Apr; 325(1):175-82. PubMed ID: 18223196 [TBL] [Abstract][Full Text] [Related]